181 related articles for article (PubMed ID: 35526056)
1. Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV.
Murray J; Meloni G; Cortes EP; KimSilva A; Jacobs M; Ramkissoon A; Crary JF; Morgello S
Acta Neuropathol Commun; 2022 May; 10(1):69. PubMed ID: 35526056
[TBL] [Abstract][Full Text] [Related]
2. Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults.
Soontornniyomkij V; Moore DJ; Gouaux B; Soontornniyomkij B; Sinsheimer JS; Levine AJ
J Neurovirol; 2019 Dec; 25(6):741-753. PubMed ID: 31144289
[TBL] [Abstract][Full Text] [Related]
3. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
4. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
[TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
[TBL] [Abstract][Full Text] [Related]
8. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
9. Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy.
Alosco ML; White M; Bell C; Faheem F; Tripodis Y; Yhang E; Baucom Z; Martin B; Palmisano J; Dams-O'Connor K; Crary JF; Goldstein LE; Katz DI; Dwyer B; Daneshvar DH; Nowinski C; Cantu RC; Kowall NW; Stern RA; Alvarez VE; Huber BR; Stein TD; McKee AC; Mez J
Mol Neurodegener; 2024 Feb; 19(1):10. PubMed ID: 38317248
[TBL] [Abstract][Full Text] [Related]
10. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
[TBL] [Abstract][Full Text] [Related]
11. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
Ilievski V; Zuchowska PK; Green SJ; Toth PT; Ragozzino ME; Le K; Aljewari HW; O'Brien-Simpson NM; Reynolds EC; Watanabe K
PLoS One; 2018; 13(10):e0204941. PubMed ID: 30281647
[TBL] [Abstract][Full Text] [Related]
12. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
14. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.
Shinohara M; Koga S; Konno T; Nix J; Shinohara M; Aoki N; Das P; Parisi JE; Petersen RC; Rosenberry TL; Dickson DW; Bu G
Brain; 2017 Dec; 140(12):3301-3316. PubMed ID: 29161341
[TBL] [Abstract][Full Text] [Related]
15. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
16. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
17. Activated microglia mitigate Aβ-associated tau seeding and spreading.
Gratuze M; Chen Y; Parhizkar S; Jain N; Strickland MR; Serrano JR; Colonna M; Ulrich JD; Holtzman DM
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34100905
[TBL] [Abstract][Full Text] [Related]
18.
Ferrari-Souza JP; Lussier FZ; Leffa DT; Therriault J; Tissot C; Bellaver B; Ferreira PCL; Malpetti M; Wang YT; Povala G; Benedet AL; Ashton NJ; Chamoun M; Servaes S; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; O'Brien JT; Rowe JB; Cohen AD; Lopez OL; Tudorascu DL; Karikari TK; Klunk WE; Villemagne VL; Soucy JP; Gauthier S; Souza DO; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
Sci Adv; 2023 Apr; 9(14):eade1474. PubMed ID: 37018391
[TBL] [Abstract][Full Text] [Related]
19. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
20. ApoE facilitates the microglial response to amyloid plaque pathology.
Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
